Xregen

BiotechnologyAngelHangzhou, China

Latest round

Angel

Last raised

Feb 2022

Total raised

$4.8M

Investors

3

About Xregen

Established in 2022 and based in Hangzhou, China, Xregen is a developer of height-enhancing technology for children, focusing on human genetic diagnosis and therapeutic technology development. As of 2023, it has more than 20 employees. Their product, Angaosu, has been launched in November 2022. The chief scientist, Academician Wen, specializes in regenerating the organism by adjusting the cellular microenvironment. The company focuses on developing height enhancement solutions for children, and also includes human genetic diagnosis and treatment technology development, bio-based material polymerization technology development, medical research, and trial development. Currently, IKids-Growth, the company's exclusive IGF-1 (growth promoting factor) height enhancement solution, has passed real-world studies.

Who invested in Xregen

3 investors across 1 round

See all investors in Xregen

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Angel

    Feb 24, 2022

    Amount

    $4.8M

    Investors

    Locked

Questions about Xregen

Who invested in Xregen?

Xregen has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Xregen raised?

Xregen has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Xregen last raise money?

Xregen's most recent round on record is a Angel, in Feb 2022.

What does Xregen do?

Established in 2022 and based in Hangzhou, China, Xregen is a developer of height-enhancing technology for children, focusing on human genetic diagnosis and therapeutic technology development.

Where is Xregen headquartered?

Xregen is headquartered in Hangzhou, China.

Which VCs invest in companies like Xregen?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Xregen's stage. Their profiles are linked below.

Raising like Xregen? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.